advanced atherosclerotic lesions. [7] [8] [9] These findings are consistent with studies showing strong positive correlations among CHOP expression, lesional cell death, and clinical plaque stage in human coronary artery and carotid lesions. 2, 10 In addition, a reverse bone marrow transplantation study in atherosclerosis-prone mice suggested that CHOP in non-bone marrow-derived lesional cells also promotes atherosclerosis. 9 However, neither the identity of the nonmyeloid-derived cell type(s) in which CHOP plays a role nor the mechanisms or atherosclerosis-related consequences have been elucidated. In this context, we sought to determine the role of CHOP in vascular smooth muscle cells (VSMCs) in atherosclerosis using a new mouse model of VSMC-specific CHOP deficiency.
Methods
An expanded Methods, including description of statistical analyses, is available in the Online Data Supplement.
Briefly, Chop/Ddit3 floxed mice were generated as described in Results and in the Online Data Supplement. The mice were then crossed onto Apoe −/− and SM22α-CreKI + mice. All mice were on the C57BL/6J background (the strain of generation for the floxed mice and at least 10 backcrosses for the others). For atherosclerosis studies, the mice were placed on a Western diet for 12 weeks. For ex vivo cell culture studies, VSMCs were cultured from aortic explants from the mice.
Results

VSMC-Specific CHOP Deficiency Reduces the Content of α-Actin-Positive Cells in Apoe −/− Atherosclerotic Lesions
Chop fl/fl mice were generated as depicted in Online Figure IA-ID (details are available in the Online Data Supplement). The mice were bred with Apoe −/− mice to generate Chop fl/fl-Apoe −/− mice, which were further bred with SM22α-CreKI + mice to generate VSMC-specific Chop-deficient mice (Chop fl/fl SM22α-CreKI + Apoe −/− ; Online Figure IIA ). Note that SM22α-CreKI + deletes floxed genes in adult SMCs and not in embryonic SMCs, thus increasing cell-type specificity. 11 The expression of CHOP was evaluated in SMCs, endothelial cells, and macrophages from Chop fl/fl Apoe −/− and Chop fl/fl SM22α-CreKI + Apoe −/− mice before and after treatment with the UPR inducer tunicamycin. Tunicamycin increased CHOP expression in all 3 cell types from control mice but only in endothelial cells and macrophages from Chop fl/fl SM22α-CreKI + Apoe −/− mice (Online Figure IIB) . Thus, CHOP is specifically deleted in SMCs among these 3 atherosclerosis-relevant cell types.
After 12 weeks of Western diet feeding, Chop fl/fl Apoe −/− and Chop fl/fl SM22α-CreKI + Apoe −/− mice did not differ significantly in terms of body weight, blood glucose, total plasma cholesterol, high-density lipoprotein cholesterol, plasma triglycerides, lipoprotein profile, or blood pressure (Online Figure III) . Thus, atherosclerotic lesions could be evaluated in the absence of major changes in systemic metabolism. Quantitative analysis of aortic root lesions revealed a ≈30% reduction in lesion area (P=0.003) and a similar decrease in necrotic area (P=0.029) in Chop fl/fl SM22α-CreKI + Apoe −/− versus Chop fl/fl Apoe −/− mice, consistent with decreased plaque progression ( Figure 1A ).
Both lesional cell content and extracellular matrix contribute to lesion size. To determine whether a decrease in one or more of these parameters contributed to the reduced lesion size in Chop fl/ fl SM22α-CreKI + Apoe −/− mice, aortic root sections were stained with DAPI (4',6-diamidino-2-phenylindole) (nuclei) to measure total cell content; immunostained for smooth muscle α-actin, F4/80, and CD11c to assess lesional content of α-actin + VSMCs, macrophages, dendritic-like cells, respectively; and stained with Masson trichrome to assess collagen. The number of cells positive for α-actin, F4/80, and CD11c and the collagen content were all significantly decreased in Chop fl/fl SM22α-CreKI + Apoe −/− lesions (Online Figure IVA-IVC), consistent with an overall decrease in lesion progression. However, only the number of lesional α-actin + VSMCs was significantly lower in the VSMC-CHOP-deficient cohort when corrected for the decrease in total lesion area, whereas the decreases in F4/80 + macrophages, CD11c + cells, extracellular matrix, and plaque necrosis were proportional to the decrease in overall lesion area ( Figure 1B ). One possible explanation for this finding is a hierarchical relationship in which SMC-CHOP deletion, by decreasing lesional SMCs, leads to a secondary decrease in overall lesion progression. Lesion size and SMC content were also lower in aortic arch lesions of Chop fl/fl SM22α-CreKI + Apoe −/− mice than in Chop fl/fl Apoe −/− mice, and en face lesion area in the descending aorta of the SMC-CHOP-deficient mice was lower as well (Online Figure VA-VD). In contrast, the content of aortic wall (media) SMCs in nonatherosclerotic chow-fed Chop fl/fl SM22α and Chop fl/fl SM22α-CreKI + mice was similar between the 2 groups of mice (Online Figure VE) .
VSMC-CHOP Deficiency Decreases the Proliferation of Aortic Explant-Derived VSMCs
The lower content of α-actin + VSMCs in the lesions of Chop fl/ fl SM22α-CreKI + Apoe −/− mice could be because of increased VSMC death. However, few apoptotic VSMCs were detected in the lesions of either group, and apoptosis did not differ between the 2 groups of mice and showed no correlation with lesional VSMC count (Online Figure VIA-VIC). Therefore, we explored the possibility that CHOP deficiency decreases VSMC proliferation and found that the lesions of Chop fl/ fl SM22α-CreKI + Apoe −/− mice showed less Ki67 + VSMCs ( Figure 1C ), which is a marker of proliferating cells. Because Ki67 is not a dynamic marker of cell proliferation, we compared the growth curves of aortic explant-derived VSMCs from the 2 groups of mice using a standard protocol, namely, incubation of serum-starved VSMCs in medium containing 10% FBS. The growth rate of CHOP-deficient VSMCs was significantly lower than that of control VSMCs ( Figure 1D ). These combined data suggest that at least 1 mechanism for the decrease in VSMCs in the lesions of Chop fl/fl SM22α-CreKI + Apoe −/− mice is decreased proliferation.
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Decreased Proliferation in CHOP-Deficient VSMCs Is Causally Associated With the Upregulation of Krüppel-Like Factor 4
We interrogated a microarray data set derived from tunicamycin-treated wild-type and CHOP-deficient murine embryonic fibroblasts for mRNAs that might be linked to VSMC proliferation. 12 One of the genes increased in CHOP-deficient murine embryonic fibroblasts was Klf4. Krüppel-like factor 4 (KLF4) inhibits VSMC proliferation, and mice lacking KLF4 exhibit enhanced neointimal formation in response to vascular injury. 13 To explore the relevance of these findings to the atherosclerosis data described here, we assayed KLF4 and α-actin in lesions from Chop fl/fl Apoe −/− and Chop fl/fl SM22α-CreKI + Apoe −/− mice using immunofluorescence microscopy. KLF4 is expressed in multiple cell types in atherosclerotic lesions, and so the goal was to compare KLF4 expression in α-actin + VSMCs versus other cells in the lesions of the 2 groups of mice. We found that the lesions of Chop fl/fl SM22α-CreKI + Apoe −/− mice had an increased content of KLF4-positive cells in the α-actin + cell population, whereas the number of KLF4-positive cells in the population of α-actin − cells was similar between the 2 groups ( Figure 2A ). We then asked whether ER-stressed SMCs in aortic explants have higher levels of KLF4 when CHOP is absent. We found that tunicamycin induced Klf4 mRNA in both Chop fl/fl SM22α-CreKI + Apoe −/− and Chop fl/fl Apoe −/− aortic VSMCs, but induction was higher in the CHOP-deficient cells ( Figure 2B ). These data suggest that ER stress induces Klf4 expression in VSMCs but that CHOP fine-tunes this expression in a suppressive manner. Klf4 mRNA and KLF4 protein were also elevated in CHOP-deficient VSMCs under the conditions of the proliferation assay, which involves serum repletion after a period of serum starvation ( Figure 2C ). Most importantly, CHOP-deficient VSMCs subjected to siRNA-mediated silencing of KLF4 no longer showed a defect in proliferation after 4 days in culture ( Figure 2D , left). Note that KL4 expression was higher in CHOP-deficient (Cre+) SMCs at day 0 and day 2, while by day 4 KL4 expression was lower in all groups and not different between the Cre-and Cre+ group ( Figure 2D , right). These data suggest that the effect of KLF4 silencing on cell proliferation at day 4 was a delayed effect from events occurring earlier in the time course. These combined data suggest that at least 1 mechanism for the decrease in proliferation in CHOP-deficient VSMCs is an increase in KLF4. 
ATF4 Is Elevated in CHOP-Deficient VSMCs and Mediates Increased KLF4 Expression
To study how CHOP suppresses Klf4 expression, we analyzed murine embryonic fibroblast chromatin-immunoprecipitationsequencing data and found that ATF4 but not CHOP directly associates with the Klf4 promoter region. 14 Therefore, we reasoned that CHOP might suppress Klf4 by downregulating ATF4, which could occur through the CHOP-GADD34 negative-feedback pathway that decreases p-eIF2α and thereby decreases ATF4 translation. 6 Consistent with the hypothesis, CHOP deficiency was associated with a decrease in Gadd34 mRNA after 12 hours of tunicamycin treatment, and after 16 hours of treatment, there were increases in p-eIF2α protein, ATF4 protein, and Klf4 mRNA ( Figure 3A) . Moreover, the levels of nuclear ATF4 and KLF4 in VSMCs were also elevated by CHOP deficiency ( Figure 3B ). To link to the atherosclerosis data, we analyzed nuclear ATF4-KLF4 coexpression and found that SMC-CHOP deficiency was associated with a higher percentage of total lesional cells that coexpressed nuclear ATF4 and KLF4 and a higher percentage that coexpressed nuclear ATF4 and α-actin (Online Figure VII) . We next verified by chromatin-immunoprecipitation analysis that ATF4 directly associates with the Klf4 promoter. Genomic fragments containing the ATF4-binding region in the Klf4 promoter were significantly enriched in tunicamycin-treated Atf4 +/+ versus Atf4 −/− murine embryonic fibroblasts ( Figure 3C ), consistent with the conclusion that ATF4 regulates Klf4 mRNA transcription. Most importantly, silencing ATF4 significantly reduced both Klf4 mRNA and KLF4 protein in tunicamycin-treated CHOP-deficient VSMCs ( Figure 3D ). The protein data show that the level of KLF4 in siAtf4-treated CHOP-deficient VSMCs was restored to the 
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Lumen level in scrambled RNA-treated WT SMCs. These combined data support the hypothesis that an increase in ATF4 in CHOPdeficient VSMCs mediates an increase in KLF4. The reason why ATF4 is higher in the face of CHOP deficiency may be because of the increase in p-eIF2α, which in turn could be explained by the decrease in CHOP-induced GADD34.
CHOP Deficiency Also Decreases Proteasomal Degradation of KLF4 Under ER Stress Conditions
In theory, CHOP deficiency could raise KLF4 by also increasing the stability of Klf4 mRNA or KLF4 protein. The former possibility does not appear to be the case, as Klf4 mRNA expression after actinomycin D (ActD) treatment was not affected by CHOP deficiency in VSMCs ( Figure 4A ). However, KLF4 protein turnover was more rapid in WT versus CHOPdeficient VSMCs after treatment with cycloheximide, an inhibitor of protein biosynthesis ( Figure 4B ). KLF4 protein is targeted for degradation by the proteasome, 15 which we confirmed by showing that MG132, a proteasome inhibitor, inhibited KLF4 protein degradation in VSMCs ( Figure 4C ). Moreover, less ubiquitin was associated with KLF4 in tunicamycin-treated CHOP-deficient VSMCs ( Figure 4D ). In contrast to the situation with KLF4, the turnover of 2 other VSMC proteins, HIF1α (hypoxia-inducible factor 1α) and Nrf2 (nuclear factor erythroid-derived 2-related factor 2), was not altered by CHOP deficiency although both proteins are also targeted for degradation by the proteasome (Online Figure VIII ). Most importantly, silencing ATF4 markedly increased KLF4 protein turnover in tunicamycin-treated CHOPdeficient VSMCs ( Figure 4E ). These data suggest that the increase in ATF4 in CHOP-deficient VSMCs raises KLF4 by 2 distinct mechanisms: transcriptional induction via ATF4 binding to the Klf4 promoter and protein stabilization via suppression of KLF4 proteasomal degradation. The molecular mechanism of the latter process remains to be determined.
Discussion
Using a newly created mouse model of cell-specific CHOP deletion, the data in this report show that CHOP deficiency in SM22α + VSMCs leads to a decrease in α-actin + VSMC content in atherosclerotic lesions in Apoe −/− mice. The proposed mechanism involves, in part, a fine-tuning module based on the suppression of ATF4 by the CHOP-GADD34-eIF2α dephosphorylation pathway and the increase in KLF4 by ATF4 ( Figure 4F ). Interestingly, there are examples of CHOP-ATF4 heterodimer affecting gene transcription, 16 and additional work will be required to determine whether this complex plays a role in Klf4 regulation in ER-stressed SMCs. In addition, ATF4 suppresses the proteasomal degradation of KLF4 by a mechanism yet to be elucidated. Decreased lesional SMCs in SMC-CHOP-deficient mice was associated with features of decreased lesion progression, namely, lower numbers of inflammatory cells, plaque necrosis, and collagen. How a decrease in intimal SMCs might lead to lower inflammatory cells remains to be determined. Other studies have suggested that lesional VSMCs can regulate lesion development by affecting lipid content and by retaining and promoting the survival of lesional inflammatory cells. 17 Moreover, a recent study provided evidence that VSMCs can be transformed into macrophage-like cells in atherosclerotic lesions, 18 but whether VSMC-CHOP affects this transformation process remains to be determined. Nonetheless, the data herein suggest that uncontrolled elevation of VSMC content in lesions can contribute to lesion progression, whereas VSMC-CHOP deficiency may suppress this process by inhibiting VSMC proliferation.
The impact of the decrease in collagen content in the SMC-CHOP-deficient lesions is an interesting topic. On the one hand, this decrease could lead to thinner fibrous caps, which is a sign of advanced plaque progression. 19 However, fibrous cap thickness was similar in the aortic root lesions of the 2 groups of mice (data not shown). On the other hand, a decrease in lesional matrix might lessen the pathological process of arterial stiffening. 20 Along these lines, it is interesting to note that silencing XBP1, a UPR effector that can have opposing actions to CHOP in the setting of prolonged ER stress, enhanced VSMC proliferation in vitro and promoted neointima formation in a murine wire injury model. 21 Pending future studies to explore these and other issues, the findings in this report, together with previous studies showing the role of macrophage CHOP in advanced lesional apoptosis and plaque necrosis, [7] [8] [9] help form a more complete picture of the cell-specific roles of the UPR and its effector CHOP in atherosclerosis. 
What Is Known?
• Smooth muscle cells (SMCs) in atherosclerotic lesions are the major source of collagen and elastin that forms a protective fibrous cap, but they may also contribute to inflammation and plaque progression. • A particular signaling molecule called Krüppel-like factor 4 acts as a suppressor of SMC proliferation in atherosclerotic lesions. • Cells in human and murine atherosclerotic lesions are known to undergo chronic endoplasmic reticulum (ER) stress, which is probably because of their exposure to certain types of lipids that affect ER function and to factors that promote intracellular oxidative stress.
What New Information Does This Article Contribute?
• Using a new mouse model in which the ER stress effector C/EBPhomologous protein (CHOP) was specifically deleted in SMCs, the study shows for the first time that CHOP regulates SMC proliferation. • Deletion of CHOP in SMCs in an atherosclerosis-prone mouse model resulted in atherosclerotic lesions that had less SMCs and less plaque progression.
• CHOP deficiency lowers SMC proliferation through feedback induction of the ER stress effector ATF4, which then transcriptionally induces Krüppel-like factor 4 and decreases its degradation.
Cells in both human and murine atherosclerotic lesions undergo chronic ER stress, but the effect of ER stress in lesional SMCs was not known. We deleted the ER stress effector CHOP in SMCs in a mouse model of atherosclerosis and found a decrease in both lesional SMC content and overall lesion progression. CHOP deletion suppressed SMC proliferation through upregulation of Krüppel-like factor 4. The mechanism involved a feedback increase in ATF4, which both enhanced the transcription of Klf4 mRNA and stabilized Krüppel-like factor 4 protein. These findings reveal a role and novel mechanism of CHOP in the progression of atherosclerotic lesions. 
Supplemental Material Detailed Methods
Generation of Chop
Verification of successful Chop gene deletion in vivo
Chop fl/fl mice were challenged with adenovirus encoding the Cre recombinase through tail vein injection, followed by treatment with Tm 2 mg/kg for 8 h. Protein and DNA were prepared from liver and/or spleen. Deletion of the exon 3 of Chop gene was verified by gel electrophoresis and sanger sequencing of the PCR product from liver genomic DNA using primers (Online Table I 
Blood glucose and plasma lipid analysis
At the end of the study, the mice were fasted overnight. A drop of blood was collected from mouse tail, and blood glucose was measured using a glucose meter (One Touch Ultra, Lifescan). Mice were then weighed, anesthetized using isoflurane, and euthanized. 
Measurement of Blood Pressure
Blood pressure was measured using a noninvasive computerized tail-cuff system (Kent Scientific Corporation, CT, USA). After the mice were placed in a plastic holder, the occlusion and sensor cuff were positioned on the base of the tail. After the mice were given time to adapt to the system, blood pressure was measured for at least three consecutive times in each mouse.
Immunochemistry and microscopy
Immunochemistry on frozen aortic root sections were performed as described previously. 2 Briefly, frozen sections were fixed in ice-cold acetone for 5 min and then 
Masson's trichrome staining
Paraffin-embedded aortic root sections were de-paraffinized and then stained with a Masson's trichrome stain kit from Sigma-Aldrich. Collagen, which was stained with Aniline blue in the kit, was quantified using ImageJ.
Isolation and culture of mouse aortic vascular smooth muscle cells (VSMCs)
VSMCs were isolated from mouse thoracic aorta by an enzymatic digestion method. 3 Cells were cultured in DMEM/F12 medium (GIBCO) supplemented with 20% FBS, penicillin/streptomycin 100U/ml before passage 6. After passage 6, cells were cultured with 10% FBS medium and used between passage 6 and 10. For serum starvation, cells were cultured with DMEM/F12 supplemented with L-glutamine 1.6 mM (Gibco), L-ascorbic acid 0.2 mM (Sigma-Aldrich), transferrin 5 µg/ml (Sigma-Aldrich), insulin 2.8 µg/ml (Gibco), penicillin/streptomycin 100 U/ml (Gibco), and Na-selenate 6.25 ng/ml (Sigma-Aldrich) for 2-3 days.
Isolation and culture of mouse lung endothelial cells (ECs)
ECs were isolated from mouse lung after digestion with collagenase as described previously. 4 Briefly, after two passages of total lung cell culture, ECs were isolated using magnetic Dynabeads (Invitrogen) conjugated with ICAM-2 antibody (BD Pharmingen).
Cells were cultured in DMEM low glucose medium (GIBCO) supplemented with 10% horse serum, penicillin/streptomycin 100U/ml, L-glutamine 1.6 mM, ECGS 50 µg/ml (Biomedical Technologies), and heparin100 µg/ml (Sigma-Aldrich). The first two passages of ECs were used in experiments.
Isolation and culture of mouse bone marrow-derived macrophages
Bone marrow-derived macrophages were separated as described previously. 5 To prepare bone marrow-derived macrophages, both ends of femurs were removed, and the marrow was flushed with RPMI medium. The flushed cells were placed through a strainer to remove debris and then pelleted by centrifugation. The cells were resuspended in DMEM containing 20% L-cell-conditioned medium, cultured for 4-5 days, and then used for the experiments.
In vitro proliferation assay
VSMC proliferation was measured as previously described. 6 Briefly, serum-starved VSMCs were incubated with cell culture medium with 10% FBS at 37°C in a CO 2 incubator. After culture for 0-4 days after serum starvation, cells were collected by trypsin digestion and counted with a hemocytometer.
Immunoblotting
Cells were lysed in a buffer containing 2% SDS, 62.5 mM Tris-HCl (pH 6.8), 10% glycerol, 50 mM DTT, and 0.01% bromphenol blue and boiled at 100ºC for 5 min. 
Quantitative RT-qPCR
Total RNA was extracted from HCs using the RNeasy kit (Qiagen). cDNA was synthesized from 2 μg total RNA using oligo (dT) and Superscript II (Invitrogen). qPCR was performed in an 7500 Real time PCR system (Applied Biosystems) using SYBR green chemistry. QuantiTect primers for Klf4, Gadd34, Hprt, and Actb were used (Qiagen).
siRNA-mediated gene silencing
siRNA sequences against murine Klf4, Atf4 and scrambled RNA, were purchased from Qiagen; the target sequence of Klf4 siRNA was CCGGTTTATATTGAATCCAAA , the target sequence of Atf4 siRNA was GACUGAGAAAUUGGAUAAGAAGCTG. The scrambled RNA and siRNA were transfected into SMCs using the basic nucleofector kit for primary SMCs and Amaxa nucleofector (Lonza) according to the manufacturer's instruction.
Chromatin immunoprecipitation (ChIP)
Atf4 +/+ and Atf4 -/-MEFs were treated with 2 µg/ml tunicamycin (Sigma-Aldrich) for 8 h, followed by cross-linking with 1% formaldehyde for 10 min and subsequent chromatin immunoprecipitation as described, using anti-ATF4 antibody (gift from Dr. Michael S.
Kilberg, University of Florida College of Medicine). 7 
Ubiquitin assay
For immunoprecipitation, VSMCs from one 100-mm dish were infected with adenovirus encoding Klf4. After 3 days, the cells were treated with MG132 for 6 h and then lysed in IP buffer (1.2 ml of 20 mM Tris-HCl pH 7.4, 100 mM NaCl, 10% glycerol, 1% NP-40, 12.5 mM N-ethylmaleimide). The lysate was mixed with 5 µg anti-KLF4 antibody and rotated at 4°C overnight, followed by adding 100 µl protein G beads and rotating for additional 2 hours at 4°C. The beads were washed three times by vortexing in IP buffer, followed by centrifugation for 5 s at 10 000 x g. The IP pellet was boiled in 2X SDS sample buffer and subjected to immunoblot analysis.
Statistical Analysis
Data are displayed as mean ± S.E.M., with the n number given in the individual figure legends. After the data were shown to fit a normal distribution, the unpaired t-test was used to assess the statistical significance of the differences in experiments with two groups, and two-way ANOVA was used for analyses in multi-group experiments.
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